UPC

Universe Pharmaceuticals INC (NASDAQ:UPC) is a Chinese pharmaceutical company founded in 2019 and headquartered in Ji'An, China. The company went public on the NASDAQ in March 2021. Universe Pharmaceuticals operates as a subsidiary of Sununion Holding Group Limited and specializes in manufacturing, marketing, and distributing traditional Chinese medicine derivative products primarily within the Chinese market. Despite being a relatively young public company, Universe Pharmaceuticals has established itself in the specialty pharmaceutical sector, focusing on products that address common chronic health conditions in elderly populations as well as cold and flu treatments.